Collegium Pharmaceutical (COLL) and Paris Hilton announced ‘Embrace Your Sparkle’, a campaign aimed at encouraging broader understanding and open dialogue about attention-deficit/hyperactivity disorder. “ADHD shows up differently for everyone, and too often those experiences are disregarded or minimized,” said Scott Dreyer, Executive Vice President, Chief Commercial Officer of Collegium Pharmaceutical. “Paris brings an authentic and powerful perspective to help shine a light on the everyday realities of living with ADHD and the importance of finding support that fits each individual.”
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on COLL:
- Collegium Pharmaceutical Earnings Call: Jornay Leads Growth
- Collegium Reports Record 2025 Results and Reaffirms Outlook
- Collegium Pharmaceutical reports Q4 adjusted EPS $2.04, consensus $2.14
- Collegium Pharmaceutical sees FY26 product revenue $805M-$825M
- Collegium Pharmaceutical Inc. (COLL) Q4 Earnings Cheat Sheet
